Controlled Release Scaffolds for Bone Tissue Engineering
被引:56
作者:
Cartmell, Sarah
论文数: 0引用数: 0
h-index: 0
机构:
Keele Univ, Inst Sci & Technol Med, Med Res Unit, Stoke On Trent ST4 7QB, Staffs, EnglandKeele Univ, Inst Sci & Technol Med, Med Res Unit, Stoke On Trent ST4 7QB, Staffs, England
Cartmell, Sarah
[1
]
机构:
[1] Keele Univ, Inst Sci & Technol Med, Med Res Unit, Stoke On Trent ST4 7QB, Staffs, England
bone tissue engineering;
controlled release;
growth factor;
scaffold;
delivery vehicle;
protein delivery;
biodegradable polymers;
polymeric drug delivery systems;
polymeric drug carrier;
microencapsulation;
FIBROBLAST-GROWTH-FACTOR;
MANDIBULAR DISTRACTION OSTEOGENESIS;
CONTROLLED LOCAL RELEASE;
MARROW STROMAL CELLS;
MORPHOGENETIC PROTEIN-2;
DELIVERY-SYSTEM;
IN-VITRO;
SODIUM-FLUORIDE;
COMPOSITE SCAFFOLDS;
SUSTAINED DELIVERY;
D O I:
10.1002/jps.21431
中图分类号:
R914 [药物化学];
学科分类号:
100705 [微生物与生化药学];
摘要:
Bone disease and trauma can sometimes create defects that require more than current clinical therapies can provide for effective healing. Scaffolds that release bioactive agents such as drugs offer additional benefits in this regard in comparison to those whose main requirements are space filling and load bearing. This review details a variety of recent research on scaffold carrier systems that release osteogenic drugs for orthopaedic treatment purposes. The controlled release scaffolds presented are created from a variety of materials (such as tricalcium phosphate, hydrogel systems and poly(D,L-lactide)) and release drugs such as statins, bisphosphonates and a variety of growth factors. (C) 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:430-441, 2009